Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 Sep 1.

Published in final edited form as: J Cardiovasc Pharmacol. 2021 Sep 1;78(3):411–421. doi: 10.1097/FJC.0000000000001082

Figure 1. — Establishment and characterization of pAVICs. Cells were positive for (A) α-SMA and (B) vimentin in pAVICs. (C) BSA (1%) was used as a negative control in order to exclude non-specific fluorescence staining. Scale bar, 50 μm. α-SMA, a-smooth muscle actin; pAVICs, porcine aortic valve interstitial cells.

Figure 1. — Establishment and characterization of pAVICs. Cells were positive for (A) α-SMA and (B) vimentin in pAVICs. (C) BSA (1%) was used as a negative control in order to exclude non-specific fluorescence staining. Scale bar, 50 μm. α-SMA, a-smooth muscle actin; pAVICs, porcine aortic valve interstitial cells.